HMOX1 and cancer: The 14 liver injury-associated oleanolic acid targets also had low somatic mutation rates in cancer, and HMOX1 had a 1% somatic mutation rate in liver cancer (Figure 6B) compared to a 5% mutation rate in cancer as a whole (Figure 6C).